BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31106359)

  • 1. The ATP-dependent chromatin remodelling enzyme Uls1 prevents Topoisomerase II poisoning.
    Swanston A; Zabrady K; Ferreira HC
    Nucleic Acids Res; 2019 Jul; 47(12):6172-6183. PubMed ID: 31106359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMO-Targeted DNA Translocase Rrp2 Protects the Genome from Top2-Induced DNA Damage.
    Wei Y; Diao LX; Lu S; Wang HT; Suo F; Dong MQ; Du LL
    Mol Cell; 2017 Jun; 66(5):581-596.e6. PubMed ID: 28552615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topoisomerase II binds nucleosome-free DNA and acts redundantly with topoisomerase I to enhance recruitment of RNA Pol II in budding yeast.
    Sperling AS; Jeong KS; Kitada T; Grunstein M
    Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12693-8. PubMed ID: 21771901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Swi2/Snf2-like protein Uls1 functions in the Sgs1-dependent pathway of maintenance of rDNA stability and alleviation of replication stress.
    Kramarz K; Litwin I; Cal-Bąkowska M; Szakal B; Branzei D; Wysocki R; Dziadkowiec D
    DNA Repair (Amst); 2014 Sep; 21():24-35. PubMed ID: 25091157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of nonhomologous end-joining pathways in surviving topoisomerase II-mediated DNA damage.
    Malik M; Nitiss KC; Enriquez-Rios V; Nitiss JL
    Mol Cancer Ther; 2006 Jun; 5(6):1405-14. PubMed ID: 16818498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressing proteasome mediated processing of topoisomerase II DNA-protein complexes preserves genome integrity.
    Sciascia N; Wu W; Zong D; Sun Y; Wong N; John S; Wangsa D; Ried T; Bunting SF; Pommier Y; Nussenzweig A
    Elife; 2020 Feb; 9():. PubMed ID: 32057297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage.
    Nitiss KC; Malik M; He X; White SW; Nitiss JL
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):8953-8. PubMed ID: 16751265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Swi2-Snf2-like protein Uls1 is involved in replication stress response.
    Cal-Bakowska M; Litwin I; Bocer T; Wysocki R; Dziadkowiec D
    Nucleic Acids Res; 2011 Nov; 39(20):8765-77. PubMed ID: 21764775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Role for VCP/p97 in the Processing of Drug-Stabilized TOP2-DNA Covalent Complexes.
    Swan RL; Cowell IG; Austin CA
    Mol Pharmacol; 2021 Jul; 100(1):57-62. PubMed ID: 33941661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyzing Top2 distribution on yeast chromosomes by chromatin immunoprecipitation.
    Baldwin M; Warsi T; Bachant J
    Methods Mol Biol; 2009; 582():119-30. PubMed ID: 19763946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual functions of the homeoprotein DLX4 in modulating responsiveness of tumor cells to topoisomerase II-targeting drugs.
    Trinh BQ; Ko SY; Barengo N; Lin SY; Naora H
    Cancer Res; 2013 Jan; 73(2):1000-10. PubMed ID: 23222298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms to Repair Stalled Topoisomerase II-DNA Covalent Complexes.
    Swan RL; Cowell IG; Austin CA
    Mol Pharmacol; 2022 Jan; 101(1):24-32. PubMed ID: 34689119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication termination at eukaryotic chromosomes is mediated by Top2 and occurs at genomic loci containing pausing elements.
    Fachinetti D; Bermejo R; Cocito A; Minardi S; Katou Y; Kanoh Y; Shirahige K; Azvolinsky A; Zakian VA; Foiani M
    Mol Cell; 2010 Aug; 39(4):595-605. PubMed ID: 20797631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atp-bound topoisomerase ii as a target for antitumor drugs.
    Wang H; Mao Y; Zhou N; Hu T; Hsieh TS; Liu LF
    J Biol Chem; 2001 May; 276(19):15990-5. PubMed ID: 11278845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicase/SUMO-targeted ubiquitin ligase Uls1 interacts with the Holliday junction resolvase Yen1.
    Bauer SL; Chen J; Åström SU
    PLoS One; 2019; 14(3):e0214102. PubMed ID: 30897139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trapped topoisomerase II initiates formation of de novo duplications via the nonhomologous end-joining pathway in yeast.
    Stantial N; Rogojina A; Gilbertson M; Sun Y; Miles H; Shaltz S; Berger J; Nitiss KC; Jinks-Robertson S; Nitiss JL
    Proc Natl Acad Sci U S A; 2020 Oct; 117(43):26876-26884. PubMed ID: 33046655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small Molecule Inhibitors Confirm Ubiquitin-Dependent Removal of TOP2-DNA Covalent Complexes.
    Swan RL; Poh LLK; Cowell IG; Austin CA
    Mol Pharmacol; 2020 Sep; 98(3):222-233. PubMed ID: 32587095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End-joining inhibition at telomeres requires the translocase and polySUMO-dependent ubiquitin ligase Uls1.
    Lescasse R; Pobiega S; Callebaut I; Marcand S
    EMBO J; 2013 Mar; 32(6):805-15. PubMed ID: 23417015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring the DNA Topoisomerase II Checkpoint in Saccharomyces cerevisiae.
    Furniss K; Vas ACJ; Lane AB; Clarke DJ
    Methods Mol Biol; 2018; 1703():217-240. PubMed ID: 29177745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rrp1, Rrp2 and Uls1 - Yeast SWI2/SNF2 DNA dependent translocases in genome stability maintenance.
    Kramarz K; Dziadkowiec D
    DNA Repair (Amst); 2022 Aug; 116():103356. PubMed ID: 35716431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.